Dr. Daniel Nomura Selected as Editor-in-Chief of the AACR Journal Molecular Cancer Therapeutics
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Daniel K. Nomura, PhD, as editor-in-chief...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Daniel K. Nomura, PhD, as editor-in-chief...
PHILADELPHIA – The American Association for Cancer Research (AACR) today joins individuals and organizations around the world in recognizing...
The American Association for Cancer Research (AACR) is increasingly concerned about the numerous executive orders and policy proposals that...
PHILADELPHIA – A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according...
PHILADELPHIA — The American Association for Cancer Research (AACR) today expressed its gratitude to Monica M. Bertagnolli, MD, for...
The study was terminated early due to low detection of ctDNA after treatment among patients with stage 1 to...
Genomic testing helped identify which patients with node-negative, HR-positive, HER2- negative breast cancer could benefit from the addition of...
Combining real-world clinical and genomic data resulted in a more accurate prediction of outcomes compared to examining clinical and...
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not...
SAN ANTONIO – Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they...